Table 6.
Treatment-Related Adverse Events
| Adverse Events | Grade 1–2 | Grade 3 | Total |
|---|---|---|---|
| Fatigue | 92(44.6%) | 0 | 92(44.6%) |
| Hypertension | 87(42.2%) | 20(9.7%) | 107(51.9%) |
| Hand-foot syndrome | 83(40.3%) | 30(14.6%) | 113(54.9%) |
| Anorexia | 60(29.1%) | 0 | 60(29.1%) |
| Hemoptysis | 46(22.3%) | 9(4.4%) | 55(26.7%) |
| Rash | 36(17.5%) | 3(1.5%) | 60(18.9%) |
| Oral mucositis | 30(14.6%) | 2(1.0%) | 32(15.5%) |
| Hoarseness | 23(11.2%) | 0 | 23(11.2%) |
| Bone marrow suppression | 15(7.3%) | 2(1.0%) | 17(8.3%) |
| Pneumonia | 6(2.9%) | 2(1.0%) | 8(3.9%) |
| Diarrhea | 6(2.9%) | 1(0.5%) | 7(3.4%) |
| Pruritus/Proteinuria | 5(2.4%) | 0 | 5(2.4%) |
| Liver dysfunction | 4(1.9%) | 0 | 4(1.9%) |
| TSH elevation | 4(1.9%) | 0 | 4(1.9%) |